AH
KRTX

Andreas Halvorsen’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Andreas Halvorsen’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,131,263
Closed -$191M – 97
2023
Q3 		$191M Buy
1,131,263
+183,308
+19% +$34.5M 0.78% 36
2023
Q2 		$206M Sell
947,955
-553,119
-37% -$119M 0.84% 40
2023
Q1 		$273M Buy
1,501,074
+317,338
+27% +$60.7M 1.28% 25
2022
Q4 		$233M Buy
1,183,736
+169,620
+17% +$36.4M 1.16% 27
2022
Q3 		$228M Sell
1,014,116
-105,244
-9% -$21.3M 1.05% 34
2022
Q2 		$142M Buy
1,119,360
+145,015
+15% +$16.7M 0.65% 45
2022
Q1 		$124M Buy
974,345
+110,681
+13% +$12.5M 0.5% 53
2021
Q4 		$113M Sell
863,664
-5,032
-0.6% -$650K 0.33% 71
2021
Q3 		$106M Buy
868,696
+46,231
+6% +$5.34M 0.29% 68
2021
Q2 		$93.8M Buy
822,465
+221,321
+37% +$25.9M 0.28% 65
2021
Q1 		$72.3M Buy
601,144
+262,944
+78% +$29.8M 0.22% 75
2020
Q4 		$34.4M Sell
338,200
-325,690
-49% -$30.2M 0.09% 84
2020
Q3 		$51.3M Buy
+663,890
New +$56.6M 0.19% 71

Other funds holding KRTX

Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

Andreas Halvorsen's KRTX Position: Q4 2023 in Review

Andreas Halvorsen sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q4 2023, closing a stake of 1,131,263 shares — an estimated $191M sold.

Andreas Halvorsen first reported a position in KRTX in Q3 2020 and held it in 13 quarters. The position peaked at $273M in Q1 2023. 328 funds tracked by Wall St. Rank hold KRTX as of Q4 2023.

  • Andreas Halvorsen reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Andreas Halvorsen sold 1,131,263 Karuna Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $191M.
  • Andreas Halvorsen first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2020 and held it in 13 quarters.
  • Andreas Halvorsen's Karuna Therapeutics, Inc. Common Stock position peaked at $273M in Q1 2023.
  • 328 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Viking Global Investors's 13F filing for Q4 2023, filed 14 Feb 2024.